Powder cocaine : how the treatment system is responding to a growing problem

Powder cocaine : how the treatment system is responding to a growing problem,  National Treatment Agency for Substance Misuse. 1st March 2010 Click on the title above to gain direct access to this report Abstract: Largest ever study of cocaine users in treatment published More people are using powder cocaine, more people are seeking help [...]

A guide for drug action teams in England which summarises the best of current commissioning practice in the drug treatment field

Commissioning for recovery: drug treatment, reintegration and recovery in the community and prisons: a guide for drug partnerships  , National Treatment Agency for Substance Misuse, 19th Jan. 2010 Click on the title above to access the full-text of this report Abstract: A guide for drug action teams in England which summarises the best of current [...]

Predicting progression of Alzheimer’s disease

Predicting progression of Alzheimer’s disease, Alzheimer’s Research & Therapy 2010, 2:2 – 28pages Rachelle S Doody et al. Abstract: Clinicians need to predict prognosis of Alzheimer’s disease (AD), and researchers need models of progression to develop biomarkers and clinical trials designs. We tested a calculated initial progression rate to see whether it predicted performance on [...]

Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance

Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance,   BMJ , 26th March 2010;340:c1079 Toni Tan, technical analyst1, Peter Barry, consultant in paediatric intensive care , honorary senior lecturer 2,3, Stefanie Reken, technical analyst, health economics1, Mark Baker, clinical adviser1, On behalf of the Guideline Development Group 1 Centre for Clinical Practice, [...]

Inflammation in Alzheimer’s disease: relevance to pathogenesis and therapy

Inflammation in Alzheimer’s disease: relevance to pathogenesis and therapy, Alzheimer’s Research & Therapy 2010, 2:1 (22 January 2010) Highly Accessed Article Elina Zotova et al    -  Division of Clinical Neurosciences, School of Medicine, University of Southampton, Mailpoint 806, Level D, South Pathology Block, Southampton General Hospital, Southampton, SO16 6YD, UK Abstract: Evidence for the involvement [...]

A systematic review of the evidence of the burden of bipolar disorder in Europe

A systematic review of the evidence of the burden of bipolar disorder in Europe, Clinical Practice Epidemology in Mental Health. 2009; 5: 3. Liberty Fajutrao et al. Abstract: Bipolar disorder is recognized as a major mental health issue, and its economic impact has been examined in the United States. However, there exists a general scarcity of [...]

Omega-3 Supplementation Delays Transition to Psychotic Disorder in Ultra-High Risk Adolescents and Young Adults

Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial, Archives of General Psychiatry. 2010;67(2):146-154 Amminger, Paul et al. Abstract: Context  The use of antipsychotic medication for the prevention of psychotic disorders is controversial. Long-chain -3 (omega-3) polyunsaturated fatty acids (PUFAs) may be beneficial in a range of psychiatric conditions, including schizophrenia. Given [...]